GSE214505 AKR1B1 knockdown A-549 3 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE214505_AKR1B1 knockdown_A-549_3_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE214505_AKR1B1 knockdown_A-549_3_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE214505_AKR1B1 knockdown_A-549_3_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE214505_AKR1B1 knockdown_A-549_3_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 1

Gene

growth arrest specific 5

Gene

small nucleolar RNA host gene 29

Gene

small nucleolar RNA host gene 5

Gene

tripartite motif containing 16 like (pseudogene)

Gene

small nucleolar RNA host gene 16

Gene

ribosomal protein SA 2

Gene

multidrug resistance-related protein

  • Gene

    Rho GTPase activating protein 23



  • Gene

    small nucleolar RNA host gene 1


  • Gene

    growth arrest specific 5


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    small nucleolar RNA host gene 5


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    ribosomal protein SA 2


  • Gene

    multidrug resistance-related protein

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.